Oral Management of Type 2 Diabetes Mellitus
dc.contributor.advisor | Pórszász, Róbert | |
dc.contributor.advisordept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
dc.contributor.author | Helou, Habib Amin | |
dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
dc.contributor.opponent | Szentmiklósi, József András | |
dc.contributor.opponent | Drimba, László | |
dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
dc.contributor.opponentdept | Kenézy Kórház, Aneszteziológiai tanszék | hu_HU |
dc.date.accessioned | 2014-06-22T17:58:57Z | |
dc.date.available | 2014-06-22T17:58:57Z | |
dc.date.created | 2014-02-28 | |
dc.date.issued | 2014-06-22T17:58:57Z | |
dc.description.abstract | The prevalence of type 2 Diabetes has been increasing at a fast pace with the potential of becoming one of the major health hazards worldwide. It is inducing a heavy burden on health providers, on health organizations and on patients alike. Etiology, pathogenesis and long term complications are well registered and explained and have been recognized for the past two millennia. The following study summarizes the presently known regimens of treatment, describes the drugs that have been historically used and lists the ones that are being prescribed. The modalities of treatment for each drug, its composition and its method of action are also outlined. The narration consolidates the present practices, available knowledge and investigates present research attempts for curbing the disease. | hu_HU |
dc.description.course | általános orvos | hu_HU |
dc.description.courselang | angol | hu_HU |
dc.description.degree | MSc/MA | hu_HU |
dc.format.extent | 51 | hu_HU |
dc.identifier.uri | http://hdl.handle.net/2437/194735 | |
dc.language.iso | en | hu_HU |
dc.rights.access | no_restriction | hu_HU |
dc.subject | Oral Management of Type 2 Diabetes Mellitus | hu_HU |
dc.subject | sulphonylureas | hu_HU |
dc.subject | biguanides | hu_HU |
dc.subject | alpha-glucosidase inhibitors | hu_HU |
dc.subject | thiazolidinediones | hu_HU |
dc.subject | incretin mimetics | hu_HU |
dc.subject | amylin analogues | hu_HU |
dc.subject | glycosurics | hu_HU |
dc.subject | targeted future remedies | hu_HU |
dc.subject.dspace | DEENK Témalista::Orvostudomány::Farmakológia | hu_HU |
dc.subject.dspace | DEENK Témalista::Orvostudomány::Belgyógyászat | hu_HU |
dc.title | Oral Management of Type 2 Diabetes Mellitus | hu_HU |
dc.title.subtitle | "Past Knowledge, Present Know How and Future Endeavors" | hu_HU |